56 related articles for article (PubMed ID: 24649229)
1. Organ preservation following radiation therapy and concurrent intra-arterial low dose cisplatin infusion for advanced T2 and T3 laryngeal cancer: Long-term clinical results from a pilot study.
Ono T; Tanaka N; Tanoue S; Miyata Y; Muraki K; Tsuji C; Ogo E; Aso T; Chitose SI; Shin B; Kakuma T; Etoh H; Hattori C; Abe T; Umeno H
Laryngoscope Investig Otolaryngol; 2020 Feb; 5(1):55-65. PubMed ID: 32128431
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy in patients with resectable laryngeal cancer: A meta-analysis.
Gao P; Gong L; Wang X
Mol Clin Oncol; 2018 Aug; 9(2):155-162. PubMed ID: 30101013
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes in poor metabolizers of cytochrome P450 2A6 with concurrent chemoradiotherapy in locally advanced head- and neck-squamous cell carcinoma.
Aggarwal D; Singh S; Ali M; Singh A; Srivastava K; Gupta R; Bhatt MLB; Devi S
Natl J Maxillofac Surg; 2022; 13(3):362-366. PubMed ID: 36683922
[TBL] [Abstract][Full Text] [Related]
4. HSP90AA1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition.
Tang F; Li Y; Pan M; Wang Z; Lu T; Liu C; Zhou X; Hu G
Oncol Res; 2023; 31(5):787-803. PubMed ID: 37547757
[TBL] [Abstract][Full Text] [Related]
5. miR-19a mediates the mechanism by which SPHK2 regulates hypopharyngeal squamous cell carcinoma progression through the PI3K/AKT axis.
Song J; Li Y; Lu T; Pan M; Wang Z; Liu C; Liao Y; Hu G
Am J Cancer Res; 2023; 13(6):2342-2359. PubMed ID: 37424828
[TBL] [Abstract][Full Text] [Related]
6. RAF1 promotes lymphatic metastasis of hypopharyngeal carcinoma via regulating LAGE1: an experimental research.
Li Y; Pan M; Lu T; Yu D; Liu C; Wang Z; Hu G
J Transl Med; 2022 Jun; 20(1):255. PubMed ID: 35668458
[TBL] [Abstract][Full Text] [Related]
7. Expression and Functional Relevance of ANXA1 in Hypopharyngeal Carcinoma with Lymph Node Metastasis.
Li L; Wang Z; Lu T; Li Y; Pan M; Yu D; Hu G
Onco Targets Ther; 2021; 14():1387-1399. PubMed ID: 33658802
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.
Chen F; Luo H; Xing L; Liang N; Xie J; Zhang J
Thorac Cancer; 2018 Jan; 9(1):59-65. PubMed ID: 29024498
[TBL] [Abstract][Full Text] [Related]
9. [Study on the indication of concurrent chemoradiotherapy for locally advanced laryngeal carcinoma].
Wang W; Huangfu H; Hou Y; Feng Y; Zhang C; Zhai S; Li M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 36(9):721-725. PubMed ID: 36036077
[No Abstract] [Full Text] [Related]
10. Laryngeal preservation in stage III/IV resectable laryngo-hypopharyngeal squamous cell carcinoma following concurrent chemoradiotherapy with capecitabine/cisplatin.
Ahn D; Kim JH; Sohn JH; Sin CM; Lee JE
Mol Clin Oncol; 2013 Jul; 1(4):685-691. PubMed ID: 24649229
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy with capecitabine/cisplatin versus 5-fluorouracil/cisplatin in resectable laryngohypopharyngeal squamous cell carcinoma.
Ahn D; Sohn JH; Kim JH; Lee JE; Park SH; Kim JC
Ear Nose Throat J; 2016 Feb; 95(2):E34-42. PubMed ID: 26930342
[TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
13. [Organ preservation in advanced laryngeal/hypopharyngeal carcinoma: lessons from the DeLOS-II trial].
Dietz A; Wichmann G; Kuhnt T; Wiegand S
HNO; 2020 Sep; 68(9):648-656. PubMed ID: 32468135
[TBL] [Abstract][Full Text] [Related]
14. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
